Indivior Pharmaceuticals, Inc 6-K/A, filed Jan 25, 2024
Indivior Pharmaceuticals, Inc. (INDV)
6-K/A
2024-01-25
For: 2024-01-25
View Original
Added on
August 22, 2026
About this 6-K/A
Indivior Pharmaceuticals, Inc filed this 6-K/A on January 25, 2024.
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
________________________
Washington, D.C. 20549
_____________________
FORM 6-K/A
_____________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
Date: January 25, 2024
Commission File Number: 001-37835
________________________________________
Indivior PLC
________________________________________
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
(Address of principal executive office)
_______________________________
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7): ☐
|
|
EXHIBIT INDEX
|
Exhibit No.
|
Description of Exhibit
|
|
99.1
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
Indivior PLC
|
|
Date: January 25,
2024
|
/s/
Kathryn Hudson
|
|
|
Name:
Kathryn Hudson
|
|
|
Title:
Company Secretary
|
Exhibit
99.1
INDIVIOR PLC (THE 'COMPANY') - DIRECTOR/PDMR SHAREHOLDINGS -
CORRECTION
The following amendment has been made
to the 'Director/PDMR Shareholding' announcement released on
December 21, 2023 at 10:33 under RNS number:
6224X
In relation to the
shares acquired by Graham Hetherington, the number of shares
purchased, date of purchase and purchase price was incorrectly
stated due to a post-trade adjustment. Details as
follows:
1.
The amount of shares purchased has been changed from 1,743 to
1,807.
2.
The purchase price has changed from £11.8901 per share to
£11.4700 per share.
3.
The purchase date has changed from December 20, 2023 to December
19, 2023.
As at the date of this announcement, Graham Hetherington has an
interest in 20,296 shares in the Company.
All other details remain unchanged. The full amended text is shown
below.
INDIVIOR PLC (THE 'COMPANY')
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS
CLOSELY ASSOCIATED WITH THEM
The Company announces that it received notification on January 23,
2024 that Graham Hetherington, a Non-Executive Director of the
Company, acquired 1,807 shares at an average price of
£11.47 per share on December 19, 2023.
Following this transaction, Graham Hetherington has an interest in
20,237 shares in the Company.
|
1
|
Details
of the person discharging managerial responsibilities / person
closely associated
|
||
|
a)
|
Name
|
Graham
Hetherington
|
|
|
2
|
Reason
for the notification
|
||
|
a)
|
Position/status
|
Chair
|
|
|
b)
|
Initial
notification /Amendment
|
Amendment
|
|
|
3
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
Indivior
PLC
|
|
|
b)
|
LEI
|
213800V3NCQTY7IED471
|
|
|
4
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transactions have been conducted
|
||
|
a)
|
Description
of the financial instrument, type of instrument
Identification
code
|
Ordinary
Shares of US$0.50
ISIN:
GB00BN4HT335
|
|
|
b)
|
Nature
of the transaction
|
Purchase of shares
|
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
£11.47
|
1,807
|
||
|
d)
|
Aggregated
information
-
Aggregated volume
-
Price
|
1,807
£11.47
|
|
|
e)
|
Date
of the transaction
|
December
19, 2023
|
|
|
f)
|
Place
of the transaction
|
London
Stock Exchange (XLON)
|
|